Details for New Drug Application (NDA): 050337
✉ Email this page to a colleague
NDA 050337 describes DYNAPEN, which is a drug marketed by Apothecon and is included in one NDA. Additional details are available on the DYNAPEN profile page.
The generic ingredient in DYNAPEN is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
The generic ingredient in DYNAPEN is dicloxacillin sodium. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the dicloxacillin sodium profile page.
Summary for 050337
| Tradename: | DYNAPEN |
| Applicant: | Apothecon |
| Ingredient: | dicloxacillin sodium |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050337
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | FOR SUSPENSION;ORAL | Strength | EQ 62.5MG BASE/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
